Welcome to our dedicated page for Carecloud news (Ticker: CCLDP), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
News and press releases related to CareCloud, Inc. and the preferred stock context of CCLDP focus on the company’s role as a healthcare technology and AI-driven solutions provider for medical practices, hospitals, integrated health systems, and other healthcare organizations. These updates highlight how CareCloud applies AI and technology-enabled tools to revenue cycle management, electronic health records, practice management, analytics, and patient experience management.
Investors following CareCloud-related news can review announcements about new AI products, strategic acquisitions, capital structure decisions, and financial performance. Examples include the launch of stratusAI Desk Agent, an AI phone receptionist designed to automate patient phone interactions and manage high-volume calls, and the introduction of stratusAI Voice Audit, a conversational intelligence platform that provides insights into call quality, volumes, and patient sentiment. Together, these products illustrate how the company is integrating generative AI into real-world healthcare workflows.
News items also cover CareCloud’s expansion in the inpatient and hospital software markets, such as the acquisition of Medsphere Systems Corporation assets and the agreement to acquire HFMA’s MAP App, a hospital benchmarking tool for revenue cycle performance. These stories describe how CareCloud is broadening its SaaS-based ecosystem with tools that complement its AI-powered revenue cycle platform and extend its reach across the full care continuum.
In addition, CareCloud’s press releases provide regular updates on quarterly results, revenue guidance, profitability trends, and preferred stock dividend policies. Communications about its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock, including dividend declarations, arrears catch-up plans, and the mandatory conversion and delisting of Series A Preferred Stock, give context for investors tracking securities associated with tickers like CCLDP and CCLDO. For ongoing insight into CareCloud’s strategy, AI roadmap, acquisitions, and capital decisions, readers can monitor this news feed as new filings and announcements are released.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.
CareCloud (Nasdaq: CCLD) is showcasing its enhanced MAP App at the HFMA Revenue Cycle Conference in Arlington, March 19, 2026, demonstrating updates made since acquiring the platform from HFMA.
The company will host a networking happy hour on March 19 and a live webinar on April 7, 2026 at 1:00 PM ET to review product updates, roadmap, and use cases.
CareCloud (Nasdaq: CCLD) will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on March 17, 2026, featuring a company fireside chat streamed live to registered attendees.
CareCloud recently reported full-year 2025 results: its first full year of positive EPS since IPO, exceeded its upsized revenue forecast range, and increased free cash flow by more than 500% over three years. A replay will be available at the company investor relations site.
CareCloud (Nasdaq: CCLD) will ring the Nasdaq Closing Bell on May 19, 2026 and host its 2026 Analyst Day at the Nasdaq MarketSite in New York City. The event will showcase new AI-powered products and a management business update on strategic priorities.
The announcement highlights CareCloud reporting its first full year of positive EPS since its IPO 12 years ago and a roughly 18% rise in its common stock over two trading days after release of full-year 2025 results.
CareCloud (Nasdaq: CCLD) reported full‑year 2025 revenue of $120.5M (+8.7% YoY), GAAP net income of $10.8M (+37.5% YoY) and its first full‑year positive GAAP EPS since its 2014 IPO of $0.10. The company closed acquisitions including Medsphere, entered inpatient software, launched AI products, generated $28.6M cash from operations and repaid its credit line.
Management issued 2026 guidance: $128–$132M revenue, $29–$31M adjusted EBITDA and GAAP EPS of $0.20–$0.23.
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
A conference call for investors will follow at 8:30 a.m. ET with a live webcast, audio options, downloadable slides, and a replay available at ir.carecloud.com/events.
CareCloud (Nasdaq: CCLD) announced a new contract with Memorial Hospital in Marysville, Ohio to deploy the HealthLine clinical supply chain platform. HealthLine, acquired via CareCloud's August 2025 purchase of Medsphere, aims to reduce supply waste, improve charge capture, and free clinicians from manual inventory tasks.
The platform delivers point-of-use scanning, automated charge capture, mobility, specialized modules for high-cost areas, and a modern architecture; CareCloud plans to add AI capabilities over coming quarters to boost efficiency and insights.
CareCloud (NASDAQ: CCLD) announced that its Wellsoft Emergency Department Information System was ranked #1 EHR for Emergency Medicine by Black Book 2026. Black Book's ranking is based on independent surveys of 33,178 physician practices and ambulatory facilities collected over nine months and highlights Wellsoft's ED-ready workflow speed, throughput visibility, and operational reliability.
Wellsoft joined CareCloud through the acquisition of Medsphere and has prior recognition from KLAS more than ten times. CareCloud said Affinity Urgent Care selected Wellsoft for its Houston-Galveston clinics, positioning the company to expand emergency-grade EDIS into the ~11,000 urgent care facility U.S. market and to integrate with its revenue cycle, analytics, and AI solutions.
CareCloud (Nasdaq: CCLD, CCLDO) declared monthly cash dividends for its 8.75% Series A and Series B perpetual preferred shares for January, February and March 2026, and an additional Series B dividend to cover an arrearage.
The declared monthly dividend per share is $0.18229 for Series A, Series B and the Series B additional payment. Ex-dividend/record dates are the last day of each month (Jan 31, Feb 28, Mar 31, 2026) and payment dates are Feb 17, Mar 16 and Apr 15, 2026. The annual preference equals 8.75% of $25.00 (or $2.1875 per share).
Series A was mandatorily converted and delisted after March 6, 2025. Series B continues to trade under CCLDO and carries scheduled redemption prices that decline over time, with special redemption terms on a Change of Control.